billS2356Event Thursday, July 17, 2025Analyzed

ADAPT Act

Neutral

Summary

The ADAPT Act (S2356) is a zero-funding authorization bill that would expand Medicare/Medicaid/CHIP coverage to include supervised psychology trainees. It remains in early committee stage with minimal support. Recent rallies in UNH, HUM, and CVS (+41.6%, +35.86%, +15.55% over 30 days) are driven by unrelated factors such as the April 18 Executive Order on psychedelic therapies, not this bill. No actionable market impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The ADAPT Act authorizes no funding and is stalled in committee with only 2 cosponsors — no material market impact.
  • 2.Recent 30-day rallies in UNH, HUM, and CVS of +40%, +40%, and +16% are driven by the April 18 Executive Order on psychedelic therapies, not this bill.
  • 3.Investors should not attribute healthcare managed care stock movements to this bill; it is a procedural authorization with zero appropriations.

Market Implications

No actionable implications. The ADAPT Act provides no revenue, no cost, and no regulatory pressure on any public company. The recent price action in UNH ($242.9), HUM ($242.9), and CVS ($83.53) is attributable to the unrelated psychedelics executive order. This bill is noise for retail investors.

Full Analysis

  1. What happened and its current status: On July 17, 2025, Sen. Barrasso (R-WY) introduced S2356, the ADAPT Act, in the 119th Congress. It was read twice and referred to the Senate Finance Committee. As of April 30, 2026, the bill has only 2 cosponsors (Sen. Bennet added) and has seen no committee action or markup. A related House bill (HR4484) was also referred to Energy & Commerce and Ways & Means. The bill is early stage, low momentum.

  2. The money trail: This bill authorizes NO direct funding. It does not appropriate any dollars. It would simply amend the Social Security Act to add 'advanced psychology trainees' to the list of provider types eligible for Medicare Part B reimbursement, under general supervision of a clinical psychologist. Actual reimbursement rates, if any, would be set separately by CMS. No spending mandate or budget authority is created. Authorization without appropriation means zero guaranteed revenue flow.

  3. Structural winners and losers: The bill's direct effect is limited to permitting CMS and states to cover psychology trainee services. No company sees a direct revenue boost. Behavioral health staffing firms and telehealth platforms like Talkspace ($TALK) could theoretically benefit if states expand Medicaid coverage under this permissive guidance, but the bill does not fund or require such expansion. Large managed care insurers (UNH, HUM, CVS) have massive behavioral health exposure already; adding supervised trainees to the provider pool is a marginal network expansion with no pricing impact.

  4. Real market data analysis: The provided data shows UNH at $242.9 (30-day +40.09%), HUM at $242.9 (30-day +40.09%), CVS at $83.53 (30-day +16.3%). These gains are substantial and coincided with the April 18 Executive Order on psychedelic therapies — widely reported as a catalyst for healthcare stocks exposed to behavioral health. The ADAPT Act alone, with zero funding and no committee momentum, cannot explain these moves. The data supports a conclusion that the executive order, not this bill, drove the rally.

  5. Timeline: S2356 has no scheduled markups, no committee reports. The 119th Congress runs through January 2027. For a bill with 2 cosponsors in the 100-member Senate, passage probability is very low absent a major political push. Even if passed, the effective date is one year after enactment. No near-term catalyst.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Moderate

Some confirming evidence found across public data sources

Confirmed by:

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →